Latin America DNA Vaccines Market 2019-2027

Market Outlook

The Latin America DNA vaccines market has been projected to burgeon in terms of revenue and expand with a CAGR of 3.90% during the forecast years 2019-2027, according to a report by the author. Brazil, Mexico and countries in rest of Latin America together constitute the DNA vaccines market in the Latin American region. The Brazilian biotechnology industry earned a total revenue of $11.4bn in 2016. Long-term demographic changes and growth in emerging industries support the development of the biotech industry. Wealth creation in this emerging industry is establishing & expanding healthcare systems and driving the increased levels of demand for biotech products. Emerging industries create larger revenue opportunities for biotechnology companies, that are increasingly targeting countries such as Brazil, and others, to supplement the sales in the mature industries of Europe and the US. In Brazil, the Agencia Nacional de Vigilancia Sanitaria (ANVISA) must be satisfied that the drugs are safe and effective before being made available for consumption, as the costs of compliance and the probability of a new product’s failure, combined with the required tests pose another barrier for entry.

Competitive Outlook
Some of the established giants in the DNA vaccines market are Dendreon Corporation (acquired by Sanpower Group), Eurogentec S.A., Inovio Pharmaceuticals, Inc., Merck & Co., Novartis AG, VGXI and Xenetic Biosciences, Inc.

1. Latin America DNA Vaccines Market - Summary

2. Industry Outlook

2.1. Market Definition
2.2. Porter's Five Forces Outlook
2.2.1. Threat of New Entrants
2.2.2. Threats of Substitute Product
2.2.3. Bargaining Power of Buyer
2.2.4. Bargaining Power of Supplier
2.2.5. Intensity of Competitive Rivalry
2.3. Vendor Scorecard
2.4. Value Chain Outlook
2.5. Regulatory Framework
2.6. Key Insights
2.7. Key Buying Outlook
2.8. Market Drivers
2.8.1. Surge in New Vaccine Development
2.8.2. Rise in the Usage of DNA Vaccines for Animal Healthcare
2.8.3. Rising Prevalence of Chronic and Infectious Diseases
2.9. Market Restraints
2.9.1. Lack of Legal and Ethical Framework
2.9.2. Stringent Government Regulations
2.10. Market Opportunities
2.10.1. Growing Demand for Gene Therapy
2.10.2. Steady Vaccines Are Easy to Store and Transport
2.10.3. Increasing Number of Clinical Trials on Humans
2.11. Market Challenges
2.11.1. Variation in the Regulatory Pathway and the Points of Consideration Regarding Environmental Valuation

3. DNA Vaccines Market Outlook - by Type

3.1. Animal DNA Vaccine
3.2. Human DNA Vaccine

4. DNA Vaccines Market Outlook - by Application

4.1. Human Disease
4.2. Veterinary Disease

5. DNA Vaccines Market Outlook - by Technology

5.1. Plasmid DNA Vaccines
5.2. Plasmid DNA Delivery

6. DNA Vaccines Market Outlook - by Region

6.1. Latin America
6.1.1.1. Brazil
6.1.1.2. Mexico
6.1.1.3. Rest of Latin America

7. Competitive Landscape

7.1. Astellas Pharma, Inc.
7.2. Dendreon Corporation (Acquired by Sanpower Group)
7.3. Eli Lilly and Company
7.4. Eurogentec S.A.
7.5. Glaxosmithkline, Inc.
7.6. Inovio Pharmaceuticals, Inc.
7.7. Madison Vaccines, Incorporated (Mvi)
7.8. Merck & Co.
7.9. Merial Limited (Acquired by Boehringer Ingelheim)
7.10. Novartis AG
7.11. Sanofi
7.12. Vgxi
7.13. Vical, Incorporated
7.14. Xenetic Biosciences, Inc.
7.15. Zoetis, Inc.

8. Methodology & Scope

8.1. Research Scope
8.2. Sources of Data
8.3. Research Methodology

List of Tables

Table 1 Latin America DNA Vaccines Market 2019-2027 ($ Million)
Table 2 Intervention and Phase of Some Diseases/Conditions
Table 3 Regulations to Follow Before Commercialization
Table 4 Temperature Requirement in Preservation for Various Vaccines
Table 5 Approaches Being Tested to Enhance the Low Immunogenicity
Table 6 Clinical Trials on Humans Involving DNA Vaccines
Table 7 Latin America DNA Vaccines Market by Type 2019-2027 ($ Million)
Table 8 Latin America DNA Vaccines Market by Application 2019-2027 ($ Million)
Table 9 Latin America DNA Vaccines Market by Technology 2019-2027 ($ Million)
Table 10 Latin America DNA Vaccines Market by Country 2019-2027 ($ Million)

List of Figures

Figure 1 Latin America DNA Vaccines Market 2019-2027 ($ Million)
Figure 2 Value Chain Analysis for DNA Vaccine Industry
Figure 3 Latin America DNA Vaccines Market in Veterinary Diseases 2019-2027 ($ Million)
Figure 4 Clinical Trials of Gene Therapy
Figure 5 Latin America DNA Vaccines Market in Animal DNA Vaccines 2019-2027 ($ Million)
Figure 6 Latin America DNA Vaccines Market in Human DNA Vaccines 2019-2027 ($ Million)
Figure 7 Latin America DNA Vaccines Market Share by Application 2018 & 2027 (%)
Figure 8 Latin America DNA Vaccines Market in Human Diseases 2019-2027 ($ Million)
Figure 9 Latin America DNA Vaccines Market in Veterinary Diseases 2019-2027 ($ Million)
Figure 10 Latin America DNA Vaccines Market in Plasmid DNA Vaccines Technology 2019-2027 ($ Million)
Figure 11 Latin America DNA Vaccines Market in Plasmid DNA Delivery Technology 2019-2027 ($ Million)
Figure 12 Brazil DNA Vaccines Market 2019-2027 ($ Million)
Figure 13 Mexico DNA Vaccines Market 2019-2027 ($ Million)
Figure 14 Rest of Latin America DNA Vaccines Market 2019-2027 ($ Million)